Labs / Assays & in vitro testing
SEED Therapeutics
Prussia, PA, United States · seedtherapeutics.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
SEED Therapeutics develops de novo molecular glue degraders for disease targets that are difficult to address with traditional therapies. It focuses on oncology, neurodegeneration, and immunology, with work centered in King of Prussia, Pennsylvania.
Their website has a general contact form; we send your quote request through it.
What they offer
Molecular glue degrader discovery
Designs de novo molecular glues to recruit E3 ligases and eliminate disease-causing proteins.
Targeted protein degradation platform development
Uses the RITE3™ platform to identify ligase-target pairs and advance degradation programs.
Preclinical degrader program development
Advances degrader programs through target selection, lead identification, and IND candidate stages.
Clinical-stage program development
Advances selected degrader programs into Phase 1 clinical trials.
What they work on
- Modalities
- Small molecule, Peptide
- Species and models
- xenograft models
- Assays and studies
- high-throughput screening, live-cell assays, proteomics, structural biology, molecular modeling
- Instruments and platforms
- LumID
- Therapeutic areas
- oncology, neurodegeneration, immunology
- Sites
- King of Prussia, USA
- Address
- 411 Swedeland Rd, Suite 1000, King of Prussia, PA, 19406
Similar labs. Mirimus, Sai Life, AssayQuant, Aurigene Pharmaceutical Services
Found in a contract services directory. Listing built from seedtherapeutics.com. Work here? Claim this listing.